Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapyM A Levesque, D Katsaros, M Massobrio, et al.Journal of Endocrinological Investigation|February 1, 1996
Glucocorticoid receptors immunoreactivity in tissue of human embryosA Costa, M P Rocci, R Arisio, et al.Anticancer Research|April 27, 1999
Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinomaE S Lianidou, M A Levesque, D Katsaros, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patientsC V Obiezu, A Scorilas, D Katsaros, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2013
A simple and reproducible prognostic index in luminal ER-positive breast cancersI Castellano, L Chiusa, A M Vandone, et al.Gynecologic Oncology|September 8, 2004
Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancerD Katsaros, W Cho, R Singal, et al.Minerva Ginecologica|April 18, 2000
[Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma]D Katsaros, S Fracchioli, H J Arts, et al.Journal of Clinical Pathology|February 25, 2006
The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinomaG Cserni, S Bianchi, V Vezzosi, et al.Annals of Surgical Oncology|March 26, 2014
A predictive tool to estimate the risk of axillary metastases in breast cancer patients with negative axillary ultrasoundT J Meretoja, P S Heikkilä, A S Mansfield, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinomaH J Arts, D Katsaros, E G de Vries, et al.Pageof 5